Meghan Lawler

Meghan Lawler has extensive experience in the field of biochemistry and affinity technology, currently serving as Head of Hit Discovery at Animol Discovery, Inc. since November 2020. Lawler has held dual roles as Director of Affinity Technology and Principal Scientist at both Animol Discovery, Inc. and Anagenex during the same period. Previous experience includes working as an Investigator in ELT Biology at GSK from July 2019 to October 2020, and completing a PhD in Chemistry at Duke University from August 2014 to May 2019, where research focused on the biochemical and biophysical characterization of protein:protein and protein:lncRNA interactions. Earlier academic roles included Graduate Teaching Assistant at Duke and several positions at Western Carolina University, culminating in a Bachelor of Science in Chemistry, ACS certified.